Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
AstraZeneca
Colorcon
Medtronic
McKinsey
McKesson

Last Updated: December 6, 2019

DrugPatentWatch Database Preview

Litigation Details for Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc. (Fed. Cir. 2015)

See Plans and Pricing

« Back to Dashboard

Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc. (Fed. Cir. 2015)

Small Molecule Drugs cited in Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc. (Fed. Cir. 2015)

Date Filed Document No. Description Snippet Link To Document
2017-05-01 133 CINV was not new. Indeed, U.S. Patent No. 5,202,333 (“’333 patent”) taught that an intravenous formulation…Helsinn owns four patents, U.S. Patent Nos. 7,947,724 (“’724 patent”), 7,947,725 (“’725 patent”), 7,960,…7,960,424 (“’424 patent”), and 8,598,219 (“’219 patent”) (collectively, “the patents-in-suit”), directed…and 9 of the ’724 patent, claim 2 of the ’725 patent, claim 6 of the ’424 patent, and claims 1, 2, …filed a fourth patent application which issued as the ’219 patent. All four patents cover the 0.25 External link to document
2016-03-08 38 ondametron arc disclosed in U.S. Pat. Nos. 4,695,578, 4,753, …724 patent, claims 2 and 9; ’725 patent, “for reducing emesis or reducing the claim 2; ’424 patent, claim…assignees of U.S. Patents No. 7,947,724 (“‘724 patent”), No. 7,947,725 (“‘725 patent”), No. 7,960,4247,960,424 (“‘424 patent”), and No. 8,598,219 (“‘219 patent”). The four patents-in-suit are listed in the…and 9 of the ‘724 patent, claim 2 of the ‘725 patent, claim 6 of the ‘424 patent, and claims 1, 2, External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Boehringer Ingelheim
Harvard Business School
Moodys
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.